Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Laurence Serradell, Sophie Wagué, Annick Moureau, Markku Nissilä & Anne-Laure Chabanon. (2021) Enhanced passive safety surveillance of a trivalent and a quadrivalent influenza vaccine in Denmark and Finland during the 2018/2019 season. Human Vaccines & Immunotherapeutics 17:4, pages 1205-1210.
Read now
Read now
Gaël Dos Santos. (2019) Challenges in implementing yearly enhanced safety surveillance of influenza vaccination in Europe: lessons learned and future perspectives. Human Vaccines & Immunotherapeutics 15:11, pages 2624-2636.
Read now
Read now
Articles from other publishers (8)
Sunho Choe, Oxana Talanova, Sooyoun Shin, Olga Syrkina & Marion Fournier. (2023) Post-Marketing Safety Surveillance of Quadrivalent Influenza Vaccine (VaxigripTetra) in Children Aged 6 to 35 Months in South Korea. Infectious Diseases and Therapy 12:6, pages 1715-1723.
Crossref
Crossref
Sonja Gandhi‐Banga, Sophie Wague, Anju Shrestha, Olga Syrkina, Oxana Talanova, Markku Nissilä, Karl Stuff & Céline Monfredo. (2022) Enhanced passive safety surveillance of high‐dose and standard‐dose quadrivalent inactivated split‐virion influenza vaccines in Germany and Finland during the influenza season 2021/22. Influenza and Other Respiratory Viruses 17:1.
Crossref
Crossref
Melanie Moeller-Arendt, Serge van de Witte, Jos Nauta, Hanka de Voogd, Jutta Rogoll & Thomas Nisslein. (2023) Enhanced passive safety surveillance of Influvac® and Influvac® Tetra: Results from seven consecutive seasons. Vaccine 41:2, pages 606-613.
Crossref
Crossref
Sookyung Lim, Xiaoling Li, Olga Syrkina & Marion Fournier. (2022) Post-marketing Surveillance of a Quadrivalent Influenza Vaccine (Vaxigrip Tetra) in South Korea. Infectious Diseases and Therapy 11:5, pages 2035-2043.
Crossref
Crossref
Olga Syrkina, Ajinkya Inamdar, Sophie Wague, Céline Monfredo, Markku Nissilä, Anne-Laure Chabanon & Laurence Serradell. (2022) Enhanced passive safety surveillance of a quadrivalent inactivated split virion influenza vaccine in Finland during the influenza season 2020/21. BMC Public Health 22:1.
Crossref
Crossref
Anne-Laure Chabanon, Sophie Wague, Annick Moureau, Markku Nissila & Laurence Serradell. (2021) Enhanced passive safety surveillance of the quadrivalent inactivated split-virion influenza vaccine (IIV4) in Finland during the 2019/20 influenza season. BMC Public Health 21:1.
Crossref
Crossref
Ashwin Kamath, Nivedita Maity & Manel Arjun Nayak. (2020) Facial Paralysis Following Influenza Vaccination: A Disproportionality Analysis Using the Vaccine Adverse Event Reporting System Database. Clinical Drug Investigation 40:9, pages 883-889.
Crossref
Crossref
. (2020) Influenza virus vaccine. Reactions Weekly 1799:1, pages 229-229.
Crossref
Crossref